A
Argenta Silver Corp
OTC:AGAGF
Argenta Silver Corp
OTC:AGAGF
Price:
0.465
USD
8.14%
Market Closed
Market Cap:
$78.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Argenta Silver Corp
OTC:AGAGF
|
CA |
|
T
|
technotrans SE
XHAM:TTR1
|
DE |
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
HK |
|
C
|
Cognizant Technology Solutions Corp
SWB:COZ
|
US |
|
Vsee Health Inc
NASDAQ:VSEE
|
US |
Balance Sheet
Balance Sheet Decomposition
Argenta Silver Corp
Argenta Silver Corp
Balance Sheet Decomposition is not available for
Argenta Silver Corp
Argenta Silver Corp
Balance Sheet
Argenta Silver Corp
Argenta Silver Corp
Currency: CAD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| PP&E Net |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| PP&E Gross |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-57%
|
1
+5%
|
0
N/A
|
0
N/A
|
0
-8%
|
0
+192%
|
0
-57%
|
0
-22%
|
0
+118%
|
24
+9 366%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
11
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Total Liabilities |
11
N/A
|
12
+7%
|
13
+6%
|
13
+2%
|
0
-97%
|
1
+41%
|
0
-76%
|
0
-23%
|
0
-17%
|
0
+7%
|
10
+11 023%
|
|
| Equity | ||||||||||||
| Common Stock |
8
|
8
|
8
|
8
|
21
|
21
|
22
|
22
|
22
|
22
|
38
|
|
| Retained Earnings |
17
|
19
|
19
|
21
|
21
|
21
|
21
|
22
|
22
|
22
|
24
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
9
N/A
|
11
-24%
|
12
-6%
|
13
-11%
|
0
+98%
|
0
-63%
|
0
N/A
|
0
-77%
|
0
-33%
|
0
+392%
|
14
+8 477%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-57%
|
1
+5%
|
0
N/A
|
0
N/A
|
0
-8%
|
0
+192%
|
0
-57%
|
0
-22%
|
0
+118%
|
24
+9 366%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
44
|
44
|
44
|
44
|
303
|
303
|
317
|
319
|
64
|
66
|
169
|
|
Switch to:
Switch to:
See Also
Discover More
